Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates


Hitesh

The COVID-19-Influenza Combination (CIC) and influenza stand-alone vaccine candidates will now be tested in a Phase 2 trial, according to Novavax, Inc., a biotechnology company committed to creating and marketing next-generation vaccines for critical infectious diseases. The CIC and influenza vaccine candidates will be evaluated for safety and efficacy (immunogenicity) […]

Carrick Therapeutics and The Menarini Group Announce Collaboration on Clinical Trials to Evaluate Samuraciclib and Elacestrant Combination


Hitesh

The Menarini Group, a renowned international private equity pharmaceutical company private sector, and Carrick Therapeutics, an oncology-focused biopharmaceutical company that discovers and develops highly distinct therapies, today announced a clinical trial collaboration and supply agreement. This agreement covers the conduct of a Phase 2 clinical trial to assess Carrick’s novel […]

Kedrion Expands Its System Of Plasma Gathering Facilities


Hitesh

The acquisition of the Czech firms UNICAplasma sro and UNICAplasma Morava sro, which run five plasma collection centres in the Czech Republic, was announced by Kedrion, an Italian global biopharmaceutical company that collects and fractionates blood plasma to make and distribute plasma-derived drugs for the treatment of serious diseases and […]

Organ Recovery Systems’ LifePort® Liver Transporter Preserves First Livers for Transplant as Part of the PILOT™ Continued Access Study


Hitesh

Organ Recovery Systems (ORS) is commemorating the first liver transplants performed at Northwestern Memorial Hospital in Chicago, Illinois, and Rutgers Medical School in New Jersey using the LifePort Liver Transporter (LLT) and Vasosol®. LLT reduces organ deterioration during preservation using oxygenated hypothermic machine perfusion (HMP), which improves patient outcomes and […]